Distribution of small magnetic particles in brain tumor-bearing rats

Journal of Neuro-Oncology

Volumn 41, Issue 2, 1999, Pages 99-105

  Pulfer, Sharon K ^a   Ciccotto, Suzanne L ^a   Gallo, James M ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Ferrofluid; Glioma models; Magnetic field; Particle size; Targeted drug delivery; Tissue distribution

Indexed keywords

DEXTRAN; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BRAIN BLOOD VESSEL; BRAIN TISSUE; BRAIN TUMOR; DRUG DELIVERY SYSTEM; GLIOMA; INTRAARTERIAL DRUG ADMINISTRATION; MAGNET; MAGNETIC FIELD; MALE; NONHUMAN; PARTICLE SIZE; RAT; TISSUE DISTRIBUTION; TISSUE LEVEL; TUMOR CELL; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN NEOPLASMS; CONTRAST MEDIA; DEXTRANS; FERROSOFERRIC OXIDE; GLIOMA; IRON; MAGNETICS; MALE; MICROSCOPY, ELECTRON; MICROSPHERES; OSMOLAR CONCENTRATION; OXIDES; PARTICLE SIZE; RATS; RATS, INBRED F344;

EID: 0032903576     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006137523591     Document Type: Article

References (33)

1. Greig NH: Drug delivery to the brain by blood-brain circumvention and drug modification. In: Neuwelt EA (ed) Implications of the Blood-Brain and its Manipulation. Plenum Publishing Company, New York, 1989, pp 311-368
2. Greig NH, Jones HB, Cavanagh JB: Blood-brain barrier integrity and host responses in experimental metastatic brain tumors. Clin Expl Metastasis 1: 229-246, 1983
3. Hirano A, Ghatak NR, Becker NH, Zimmerman HM: A comparison of the fine structure of small blood vessels in intracranial and retroperitoneal malignant lymphomas. Acta Neurophathol 27: 93-104, 1974
4. Deane BR, Lantos TA: The vasculature of experimental brain tumors, Part II. A quantitative assessment of morphological abnormalities. J Neurol Sci 49: 67-77, 1981
5. Nishao S, Ohta M, Abe M, Kitamura K: Microvascular abnormalities in ethylnitrosourea (ENU)-induced rat brain tumors: structural basis for altered blood-brain barrier function. Acta Neuropathol 59: 1-10, 1983
6. Groothius DR, Fischer JM, Lapin G, Bigner DD, Vick NA: Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropath Exp Neuro 41: 164-185, 1982
7. Warnke PC, Friedman HS, Bigner DD, Groothius DR: Simultaneous measurements of blood flow and blood-to-tissue transport in xenotransplanted medulloblastomas. Cancer Res 47: 1687-1690, 1987
8. Levin VA, Freeman-Dove M, Landahl HD: Permeability characteristics of brain adjacent to tumor in rats. Arch Neurol 32: 785-791, 1975
9. Widder KJ, Senyei AE, Scarpelli DG: Magnetic microspheres: A model system for site specific drug delivery in vivo. Proc Soc Exp Biol Med 58: 141-146, 1978
10. Widder KJ, Senyei AE: Magnetic microspheres: A vehicle for selective targeting of drugs. In: Ihler GM (ed) Methods of Drug Delivery. Pergamon Press, Oxford, 1989, pp 39-57
11. Gupta PK, Hung CT: Magnetically controlled targeted microcarrier systems. Life Sci 44: 175-186, 1989
12. Gallo JM, Gupta PK, Hung CT, Perrier DG: Evaluation of drug delivery following the administration of magnetic albumin microspheres containin adriamycin to the rat. J Pharm Sci 78: 190-194, 1989
13. Widder KJ, Morris RM, Poore G, Jr DPH, Senyei AE: Tumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin. Proc Natl Acad Sci 78: 579-581, 1981
14. Widder KJ, Morris RM, Poore GA, Howards DP, Senyei AE: Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: A total remission in Yoshida sarcoma-bearing rats. Eur J Cancer Clin Oncol 19: 135-139, 1983
15. Morimoto Y, Okumura MM, Sugibayashi K, Kato Y: Preparation and magnetic guidance of magnetic albumin microspheres for site specific drug delivery in vivo. J Pharm Dyn 4: 624-631, 1981
16. Widder KJ, Marino PA, Morris RM, Howard DP, Poore GA, Senyei AE: Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: Ultrastructural evaluation of microsphere disposition. Eur J Cancer Clin Oncol 19: 1941-147, 1983
17. Gupta PK, Hung CT, Rao NS: Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats. J Pharm Sci 78: 290-294, 1989
18. Devineni D, Klein-Szanto A, Gallo JM: Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors. J Neuro-Onc 24: 143-152, 1995
19. Hassan EE, Gallo JM: Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. J Drug Targeting 1: 7-14, 1993
20. Gallo JM, Hassan EE: Receptor-Mediated Magnetic Carriers: Basis for Targeting. Pharm Res 5: 300-304, 1988
21. Wusteman FS: The involvement of glycosaminoglycans at the endothelium. In: Cryer A (ed) Biochemical Interactions at the Endothelium. Elsevier Scientific Publishers, Amsterdam, 1983, pp 79-109
22. Ausprunk DH, Boudreau CL, Nelson DA: Proteoglycans in the microvasculature. Am J Pathol 101: 353-366, 1981
23. Simionescu N, Simionescu M, Palade GE: Differentiated microdomains on the luminal surface of the capillary endothelium. J Cell Biol 90: 605-613, 1981
24. Pardridge WM: Recent advances in blood-brain barrier transport. Ann Rev Pharmacol Toxicol 28: 25-39, 1988
25. Kumagai AK, Eisenberg JB, Pardridge WM: Absorptive-mediated endocytosis of cationized albumin and a b-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. J Biol Chem 262: 15214-15291, 1987
26. Pitha J: Polymer-cell surface interactions and drug targeting. In: Goldberg EP (ed) Target Drugs. John Wiley and Sons, New York, 1983, pp 113-126
27. Pulfer SK, Gallo JM: Targeting magnetic microspheres to brain tumors. In: Hafeli U, Schutt W, Teller J, et al (eds) Scientific and Clinical Applications of Magnetic Carriers. Plenum Press, New York, 1997, pp 445-455
28. Pulfer SK, Gallo JM: Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. J Drug Targeting, in press, 1998
29. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jam RK: Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54: 3352-3356, 1994
30. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torcilin VP, Jain RK: Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55: 3752-3756, 1995
31. Heath TD, Lopez NG, Papahadjopoulos D: The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-γ-aspartate to cells in vitro. Biochim Biophys Acta 820: 74-84, 1985
32. Litzinger DC, Buiting AM, Rooijen Nv, Huang L: Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta 1190: 99-107, 1994
33. Yamaoka T, Tabata Y, Ikada Y: Blood clearance and organ distribution of intravenously administered polystyrene microspheres of different size. J Bioactive Comp Pol 8: 220-235, 1993